Table of Contents
GoRocky, a Philippines-based telehealth platform focused on men’s health and chronic care, acquired Kindred Health, a hybrid women’s health clinic, marking the GoRocky Kindred Health acquisition as the company’s first move into women’s health services.
What Kindred Health Brings to the GoRocky Kindred Health Acquisition
Founded by nurse Jessica de Mesa-Lim, Kindred Health offers consultations, diagnostics, vaccines, ultrasounds, and specialized care spanning infertility, menopause, and infectious diseases through its virtual platform and a flagship clinic in Bonifacio Global City, which will remain open following the acquisition.
GoRocky’s Background Before This Deal
Providing virtual care for men’s sexual health, hair loss, and weight management, GoRocky expanded into chronic care after raising $2 million in 2025. This prior fundraising and chronic care expansion laid the groundwork for the company’s broader ambitions beyond its original men’s health focus.
Why Women’s Health Made Sense for This GoRocky Kindred Health Acquisition
The deal marks GoRocky’s first move into women’s health, driven by growing demand as more than 60% of its weight management patients are women. This existing patient demographic data gave GoRocky a clear signal that expanding into women’s health services could meet demand already present within its own user base rather than requiring the company to build an entirely new market from scratch.
The Combined Platform’s Ambition
Together, GoRocky aims to build an integrated platform for gender-specific and chronic care, similar to U.S.-based Hims & Hers, positioning the combined company within a business model that has proven successful in other markets pairing consumer telehealth with targeted, gender-specific service lines.
How GoRocky Plans to Enhance Kindred’s Model Within This Acquisition
Enhancing Kindred’s existing care model, GoRocky will layer its network of licensed doctors, partner pharmacy, medical records system, diagnostics, and order management system to streamline the patient experience. This integration approach suggests GoRocky intends to preserve Kindred’s clinical specialization while applying its own operational infrastructure to expand capacity and service delivery.
Leadership’s Priorities for the Transition
“Our first priority is to serve existing patients better: 24/7 support, an expanded doctor network, and more treatment options as determined by our doctors, while ensuring continuity of care throughout the transition,” said GoRocky CEO Kiyanusch Braun. “From there, we will grow care across Kindred’s flagship clinic in BGC and online to millions of patients to come, adding services for menopause, metabolic health, mental health, and sexual health.”
What This GoRocky Kindred Health Acquisition Signals for Southeast Asian Telehealth
By pursuing an acquisition strategy modeled on Hims & Hers’ integrated gender-specific care approach, GoRocky is positioning itself to compete for a broader share of the Philippine telehealth market spanning both men’s and women’s health services under a single platform. Given the company’s stated plan to add menopause, metabolic health, mental health, and sexual health services following this acquisition, GoRocky appears to be building toward a comprehensive chronic and gender-specific care ecosystem rather than treating this deal as a standalone expansion.
What to Watch Going Forward
As GoRocky works to integrate Kindred’s clinical operations with its own doctor network, pharmacy partnerships, and technology infrastructure, industry observers will likely watch how effectively the combined platform scales beyond Kindred’s existing Bonifacio Global City clinic and virtual patient base. Given Braun’s stated ambition to reach “millions of patients,” this GoRocky Kindred Health acquisition may serve as an early test case for whether the Hims & Hers-style integrated telehealth model can successfully translate to the Philippine and broader Southeast Asian healthcare market.
For more healthcare industry updates, insights and news, visit DistilINFO. Click here to subscribe to stay informed.
